Inventor · disambiguated record
Birgit Schultes
Also filed as: SCHULTES BIRGIT · SCHULTES BIRGIT C · SCHULTES BIRGIT CORINNA
10 granted patents·24 pending applications·99 citations·filing 1998–2024
87Inventor score
Files withMOMENTA PHARMACEUTICALS INC8ALTAREX MEDICAL CORP7INTELLIA THERAPEUTICS INC4ALTAREX INC3ADVANCED IMMUNE THERAPEUTICS INC2
Top patents by PatentIndex Score
34 records- 0190US6689355B2Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cellsALTAREX INC·Filed 2001·Granted Feb 10, 2004·37 cites·21 claims
- 0286US11661456B2Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted May 30, 2023·4 cites·4 claims
- 0381US6881405B2Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 1999·Granted Apr 19, 2005·45 cites·9 claims
- 0476US2024052040A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0575US8697079B2IgE antibodies for the treatment of cancerPENICHET MANUEL L·Filed 2012·Granted Apr 15, 2014·5 cites·18 claims
- 0671US8038994B2Combination therapy for treating diseaseQUEST PHARMATECH INC·Filed 2004·Granted Oct 18, 2011·3 cites·20 claims
- 0771US2008311127A1Combination therapy for treating diseaseALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 0870US2025262302A1Compositions and Methods for Reducing MHC Class I in a CellINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0967US2025276090A1Methods and Compositions for Genetically Modifying a CellINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1065US2008206318A1Therapeutic compositions that alter the immune responseMADIYALAKAN RAGUPATHY·Filed 2007·Application pending·0 cites
- 1165US2020087402A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1263US2025268940A1Chimeric antigen receptor compositions and usesINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1361US2016257754A1Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1457US7579445B2Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 2004·Granted Aug 25, 2009·0 cites·9 claims
- 1557US2008220012A1Therapeutic Compositions that alter the immune responseMADIYALAKAN RAGUPATHY·Filed 2007·Application pending·0 cites
- 1657US2005048059A1Therapeutic binding agents against MUC-1 antigen and methods for their useALTAREX INC·Filed 2004·Application pending·0 cites
- 1757US2009220493A1Reagents and methods for inducing an immune response to prostate specific antigenALTAREX MEDICAL CORP·Filed 2007·Application pending·0 cites
- 1856US2004191236A1Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cellsFiled 2003·Application pending·0 cites
- 1956US2009291075A1Binding agents and their use in targeting tumor cellsALTAREX MEDICAL CORP·Filed 2008·Application pending·0 cites
- 2055US2005260208A1Binding agents and their use in targeting tumor cellsALTAREX MEDICAL CORP·Filed 2003·Application pending·0 cites
- 2150US2011256124A1METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASEADVANCED IMMUNE THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2248US2021340530A1Compositions and Methods for ImmunotherapyINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2346US2005031619A1Therapeutic compositions that alter the immune responseFiled 2002·Application pending·0 cites
- 2444US8945566B2Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of diseaseSCHULTES BIRGIT C·Filed 2012·Granted Feb 3, 2015·0 cites·8 claims
- 2544US2005271649A1Therapeutic adjuvantSCHULTES BIRGIT C·Filed 2003·Application pending·0 cites
- 2642US2016120896A1Polysaccharide compositions and related methodsMOMENTA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2740US12391759B2Methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Aug 19, 2025·0 cites·3 claims
- 2838US2016317569A1Methods of manufacturing polysaccharide compositionsMOMENTA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2938US2020181226A1Antibody-coupled t cell receptor constructs and therapeutic uses thereofUNUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3036US7361346B1Therapeutic compositions that produce an immune responseALTAREX INC·Filed 1998·Granted Apr 22, 2008·2 cites·37 claims
- 3136US2011091466A1IgE ANTIBODIES FOR THE TREATMENT OF CANCERADVANCED IMMUNE THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 3234US7318921B2Therapeutic compositions that alter the immune responseALTAREX MEDICAL CORP·Filed 1999·Granted Jan 15, 2008·3 cites·76 claims
- 3330US2012183976A1Methods of assessing activity of a polysaccharide compositionZHOU HE·Filed 2010·Application pending·0 cites
- 3427US2017173070A1Methods of administering lmwhMOMENTA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →